نتائج البحث - Nabendu S Chatterjee

Safety and efficacy of omaveloxolone v/s placebo for the treatment of Friedreich's ataxia in patients aged more than 16 years: a systematic review حسب Ankita Umrao, Monika Pahuja, Nabendu Sekhar Chatterjee

احصل على النص الكامل

Smartphone camera‐based analysis of ELISA using artificial neural network حسب Somjit Nath, Subhannita Sarcar, Biswendu Chatterjee, Rhishita Chourashi, Nabendu Sekhar Chatterjee

احصل على النص الكامل

Development of prospective hospital-based venous thromboembolism registry across India: a study protocol حسب Balram Bhargava, M V Rao, Narendra Arora, Heena Tabassum, Sumit Aggarwal, Geetha R Menon, Sagnik Chakraborty, Nabendu S Chatterjee

احصل على النص الكامل

A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials حسب Sowparnika Treasa Sabu, Shravan Venkatraman, Jerin Jose Cherian, Saibal Das, Monika Pahuja, Tulsi Adhikari, Shoibal Mukherjee, Nabendu Sekhar Chatterjee, Nilima Arun Kshirsagar

احصل على النص الكامل

Sodium butyrate inhibits the expression of virulence factors in Vibrio cholerae by targeting ToxT protein حسب Sushmita Kundu, Suman Das, Priyanka Maitra, Prolay Halder, Hemanta Koley, Asish K. Mukhopadhyay, Shin-ichi Miyoshi, Shanta Dutta, Nabendu Sekhar Chatterjee, Sushmita Bhattacharya

احصل على النص الكامل

Deciphering the possible role of ctxB7 allele on higher production of cholera toxin by Haitian variant Vibrio cholerae O1. حسب Arindam Naha, Rahul Shubhra Mandal, Prosenjit Samanta, Rudra Narayan Saha, Sreeja Shaw, Amit Ghosh, Nabendu Sekhar Chatterjee, Pujarini Dutta, Keinosuke Okamoto, Shanta Dutta, Asish Kumar Mukhopadhyay

احصل على النص الكامل

The Vibrio cholerae colonization factor GbpA possesses a modular structure that governs binding to different host surfaces. حسب Edmond Wong, Gustav Vaaje-Kolstad, Avishek Ghosh, Ramon Hurtado-Guerrero, Peter V Konarev, Adel F M Ibrahim, Dmitri I Svergun, Vincent G H Eijsink, Nabendu S Chatterjee, Daan M F van Aalten

احصل على النص الكامل

Increasing early phase clinical trials capacity in India حسب Jerin Jose Cherian, Aruvi Poomali, Aparna Mukherjee, Taruna Madan Gupta, Bikash Medhi, Shoibal Mukherjee, Alangudi Sankaranarayanan, Nilanjan Saha, Vikram Gota, Ramachandra Subbaraya Gudde, Monika Pahuja, Saibal Das, Nabendu Sekhar Chatterjee, Rubina Bose, Nilima Kshirsagar, Rajeev Singh Raghuvanshi

احصل على النص الكامل